A Randomized, Double-blind, Phase III Clinical Trial to Evaluate the Efficacy and Safety of PRO-148 Versus Systane®, in Patients With Mild to Moderate Dry Eye

Trial Profile

A Randomized, Double-blind, Phase III Clinical Trial to Evaluate the Efficacy and Safety of PRO-148 Versus Systane®, in Patients With Mild to Moderate Dry Eye

Recruiting
Phase of Trial: Phase III

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs PRO 148 (Primary) ; Polyethylene glycols; Propylene glycol
  • Indications Dry eyes
  • Focus Therapeutic Use
  • Sponsors Laboratorios Sophia
  • Most Recent Events

    • 19 May 2014 Trial status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 19 May 2014 Planned end date changed from 1 May 2014 to 1 Aug 2014 as reported by ClinicalTrials.gov.
    • 11 Apr 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top